Nationwide
A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia
Ascendis Pharma A/S
Ph 2·~3yr·3 sites in MN, TX, WI
Ascendis Pharma A/S
QED Therapeutics, a BridgeBio company
Tyra Biosciences, Inc